Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial

Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The record no longer lists a 2026 *Blood Advances* article reporting the Phase 1 study of sovleplenib (HMPL-523) in relapsed or refractory lymphoma, along with the note explaining that publications are drawn from PubMed.
    Difference
    0.2%
    Check dated 2026-11-16T13:21:21.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for HMPL-523 in relapsed or refractory lymphoma is now available, with study design, eligibility criteria, locations, and outcome measures. It states that the study was terminated by the sponsor and is no longer recruiting, and includes posted results and study documents.
    Difference
    74%
    Check dated 2026-11-09T13:16:27.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s revision identifier changed from v3.7.2 to v3.8.0. The study record area still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:58:43.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 error.
    Difference
    1%
    Check dated 2026-10-26T14:29:44.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer's site revision label updates from v3.7.1 to v3.7.2 while the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-19T14:09:56.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:46.000Z thumbnail image

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.